Msx1 and Msx2 regulate survival of secondary heart field precursors and post-migratory proliferation of cardiac neural crest in the outflow tract

Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center and Hospital, University of Southern California Keck School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA.
Developmental Biology (Impact Factor: 3.55). 09/2007; 308(2):421-37. DOI: 10.1016/j.ydbio.2007.05.037
Source: PubMed


Msx1 and Msx2 are highly conserved, Nk-related homeodomain transcription factors that are essential for a variety of tissue-tissue interactions during vertebrate organogenesis. Here we show that combined deficiencies of Msx1 and Msx2 cause conotruncal anomalies associated with malalignment of the cardiac outflow tract (OFT). Msx1 and Msx2 play dual roles in outflow tract morphogenesis by both protecting secondary heart field (SHF) precursors against apoptosis and inhibiting excessive proliferation of cardiac neural crest, endothelial and myocardial cells in the conotruncal cushions. During incorporation of SHF precursors into the OFT myocardium, ectopic apoptosis in the Msx1-/-; Msx2-/- mutant SHF is associated with reduced expression of Hand1 and Hand2, which from work on Hand1 and Hand2 mutants may be functionally important in the inhibition of apoptosis in Msx1/2 mutants. Later during aorticopulmonary septation, excessive proliferation in the OFT cushion mesenchyme and myocardium of Msx1-/-; Msx2-/- mutants is associated with premature down-regulation of p27(KIP1), an inhibitor of cyclin-dependent kinases. Diminished accretion of SHF precursors to the elongating OFT myocardium and excessive accumulation of mesenchymal cells in the conotruncal cushions may work together to perturb the rotation of the truncus arteriosus, leading to OFT malalignment defects including double-outlet right ventricle, overriding aorta and pulmonary stenosis.

Download full-text


Available from: Yi-Hui Chen, Mar 05, 2015

Click to see the full-text of:

Article: Msx1 and Msx2 regulate survival of secondary heart field precursors and post-migratory proliferation of cardiac neural crest in the outflow tract

6.22 MB

See full-text
  • Source
    • "been regarded as important [48]. In addition, large numbers of intermediate signals, such as Tb  20, Twist1, periostin, cadherin- 11, Sox9 and Msx1/2, are responsible for valvulogenesis [49] [50] [51] [52]. Thus, the ultimate structure of the adult valve is the result of a complex interplay between cells, matrix, cytokines and growth factors over relatively long periods. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Tissue engineered heart valves offer a promising alternative for the replacement of diseased heart valves avoiding the limitations faced with currently available bioprosthetic and mechanical heart valves. In the paradigm of tissue engineering, a three-dimensional platform - the so-called scaffold - is essential for cell proliferation, growth, and differentiation as well as the ultimate generation of a functional tissue. A foundation for success in heart valve tissue engineering is recapitulation of the complex design and diverse mechanical properties of a native valve. This article reviews technological details of the scaffolds that have been applied to date in heart valve tissue engineering research.
    Acta biomaterialia 03/2014; 10(7). DOI:10.1016/j.actbio.2014.03.014 · 6.03 Impact Factor
  • Source
    • "Gata4 deficient [72] Smad7 deficient [70] Cpsg2 deficient [73] RPP-J (Notch) deficient [74] ALK2, ALK3, BMP-2, (redundant roles of BMP-4, -5, -6, -7) deficient [75] [76] [77] [78] [79] For recent review: [80] TGFbRII deficient [81] Cx40 deficient [82] Cx45 deficient [83] CHF1/Hey1 deficient [84] Trisomy 16 deficient [85] Adm19 deficient [86] SHP2 Noonan Enlarged cushion [87] Tbx20 deficient [88] Endoglin deficient [89] twist deficient [88] [90] Sox9 deficient [91] PDK1 deficient [92] Fog2 Enlarged cushion [93] Ezh2 deficient [54] Mmp15 snail deficient [94] Msx1/2 deficient [95] Smad6 deficient [96] Slug deficient [97] Irx3,5 deficient [98] RA deficient [99] [100] [101] [102] Tbx2(misexpression in myocardium) Excess EMT [45] MAPK pathway MEKK4 deficient [103] Versican deficient [73] the ten commandments proposed by Dr Harken in order to design the best prosthetic valve [67]. The main issue in this therapeutic approach is to find the right cell population to repopulate the decellularized valve. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The cardiac valves are targets of both congenital and acquired diseases. The formation of valves during embryogenesis (i.e., valvulogenesis) originates from endocardial cells lining the myocardium. These cells undergo an endothelial-mesenchymal transition, proliferate and migrate within an extracellular matrix. This leads to the formation of bilateral cardiac cushions in both the atrioventricular canal and the outflow tract. The embryonic origin of both the endocardium and prospective valve cells is still elusive. Endocardial and myocardial lineages are segregated early during embryogenesis and such a cell fate decision can be recapitulated in vitro by embryonic stem cells (ESC). Besides genetically modified mice and ex vivo heart explants, ESCs provide a cellular model to study the early steps of valve development and might constitute a human therapeutic cell source for decellularized tissue-engineered valves. This article is part of a Special Issue entitled: Cardiomyocyte Biology: Cardiac Pathways of Differentiation, Metabolism and Contraction.
    Biochimica et Biophysica Acta 10/2012; 1833(4). DOI:10.1016/j.bbamcr.2012.09.013 · 4.66 Impact Factor
  • Source
    • "In the outflow tract of the heart, Msx genes are required to inhibit excessive proliferation of post-migratory NCCs (Chen et al., 2007). In contrast, Msx genes do not seem to play a role in proliferation of the NC-derived cells that contribute to the cranial ganglia and the first pharyngeal arch, but in preventing their apoptosis (Ishii et al., 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Vessels are primarily formed from an inner endothelial layer that is secondarily covered by mural cells, namely vascular smooth muscle cells (VSMCs) in arteries and veins and pericytes in capillaries and veinules. We previously showed that, in the mouse embryo, Msx1(lacZ) and Msx2(lacZ) are expressed in mural cells and in a few endothelial cells. To unravel the role of Msx genes in vascular development, we have inactivated the two Msx genes specifically in mural cells by combining the Msx1(lacZ), Msx2(lox) and Sm22α-Cre alleles. Optical projection tomography demonstrated abnormal branching of the cephalic vessels in E11.5 mutant embryos. The carotid and vertebral arteries showed an increase in caliber that was related to reduced vascular smooth muscle coverage. Taking advantage of a newly constructed Msx1(CreERT2) allele, we demonstrated by lineage tracing that the primary defect lies in a population of VSMC precursors. The abnormal phenotype that ensues is a consequence of impaired BMP signaling in the VSMC precursors that leads to downregulation of the metalloprotease 2 (Mmp2) and Mmp9 genes, which are essential for cell migration and integration into the mural layer. Improper coverage by VSMCs secondarily leads to incomplete maturation of the endothelial layer. Our results demonstrate that both Msx1 and Msx2 are required for the recruitment of a population of neural crest-derived VSMCs.
    Development 07/2011; 138(14):3055-66. DOI:10.1242/dev.063214 · 6.46 Impact Factor
Show more